Valuation: Alkem Laboratories Limited

Market Cap 646B 6.75B 5.78B 5.41B 4.95B 9.29B 9.41B 63.9B 24.92B 324B 25.34B 24.79B 1,073B P/E 2027 *
28.1x
P/E 2028 * 24.5x
Enterprise Value 633B 6.61B 5.66B 5.3B 4.85B 9.1B 9.22B 62.61B 24.41B 318B 24.83B 24.28B 1,051B EV / Sales 2027 *
3.79x
EV / Sales 2028 * 3.33x
Free-Float
37.56%
Yield 2027 *
0.91%
Yield 2028 * 1.02%
1 day-0.05%
1 week-0.39%
Current month-6.18%
1 month-4.58%
3 months-0.76%
6 months+0.09%
Current year-1.96%
1 week 5,315.7
Extreme 5315.7
5,512.9
1 month 5,173.5
Extreme 5173.5
5,875.8
Current year 5,085
Extreme 5085
5,933
1 year 5,085
Extreme 5085
5,933
3 years 3,440.05
Extreme 3440.05
6,440
5 years 2,835
Extreme 2835
6,440
10 years 1,400
Extreme 1400
6,440
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 01/02/2024
Director TitleAgeSince
Director/Board Member 44 09/08/2013
Director/Board Member 63 11/02/2008
Director/Board Member 45 11/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%-0.39% - - 6.75B
+0.88%+6.38%+76.86%+128.23% 1,109B
+1.07%+3.80%+51.03%+61.48% 644B
+1.20%+6.21%+26.47%+76.45% 463B
+1.02%+3.67%+43.14%+47.27% 371B
+0.85%+2.97%+24.48%+42.54% 301B
+1.26%+4.54%+2.20%+14.84% 256B
+1.88%+5.81%+48.54%+68.52% 234B
+1.59%+0.87%-12.95%-51.91% 205B
+1.87%+5.61%+25.81%+92.42% 178B
Average +1.02%+3.00%+31.73%+53.32% 417.9B
Weighted average by Cap. +1.07%+3.26%+44.58%+72.65%

Financials

2027 *2028 *
Net sales 167B 1.75B 1.5B 1.4B 1.28B 2.4B 2.43B 16.53B 6.45B 83.89B 6.55B 6.41B 277B 186B 1.94B 1.66B 1.56B 1.42B 2.67B 2.71B 18.38B 7.17B 93.3B 7.29B 7.13B 309B
Net income 23.14B 242M 207M 194M 177M 333M 337M 2.29B 893M 11.63B 908M 888M 38.45B 27.15B 284M 243M 227M 208M 391M 396M 2.69B 1.05B 13.64B 1.07B 1.04B 45.12B
Net Debt -13.08B -137M -117M -110M -100M -188M -191M -1.29B -505M -6.57B -513M -502M -21.73B -28.06B -293M -251M -235M -215M -404M -409M -2.78B -1.08B -14.1B -1.1B -1.08B -46.62B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
21/08/26 5,397.50 -0.05% 23,180
20/08/26 ₹5,400.00 +0.36% 126,976
19/08/26 ₹5,380.50 -1.73% 127,066
18/08/26 ₹5,475.00 +1.77% 31,263
17/08/26 ₹5,380.00 -0.35% 10,900
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,400.00INR
Average target price
5,948.55INR
Spread / Average Target
+10.16%

Quarterly revenue - Rate of surprise